Our studies assess several related research questions from different angles so that we can comprehensively evaluate established and novel mechanisms of hypertension and optimize strategies to improve blood pressure control.

ARCH-ADT

Full Title: Autonomic and Renal Contributions to Hypertension with Androgen Deprivation Therapy

NCT: NCT05700903 (Link: https://clinicaltrials.gov/study/NCT05700903)

Principal Investigator: Matthew Babcock, PhD

Co-Investigators: Kerrie Moreau, PhD, Jessica Kendrick, MD, William Cornwell, III, MD, Petter Bjornstad, MD, Elizabeth Kessler, MD, Michael Joyner, MD, William Farquhar, PhD

This study aims to determine whether androgen deprivation therapy for treating prostate cancer affects automic and/or renal function.

Sponsor: NIH/NHLBI, Colorado Clinical and Translational Sciences Institute (CCTSI)